Odysight.ai Inc.
For the period ended Dec 31, 2024. Filed Mar 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Consolidated Financial Statements
NOTE 1 –GENERAL:
| a. | Odysight.ai Inc (the “Company”), formerly known as ScoutCam Inc., was incorporated under the laws of the State of Nevada on March 22, 2013. |
| The Company’s wholly owned subsidiary, Odysight.ai Ltd (“Odysight.ai”), formerly known as ScoutCam Ltd., was incorporated in the State of Israel on January 3, 2019, and was merged into the Company on December 31, 2019, in a share exchange transaction, following which the surviving operations of the merged entity were the operations of Odysight.ai. | |
| On February 28, 2024, D. VIEW Ltd., a wholly owned subsidiary of the Company was incorporated in the State of Israel to act as a local representative for the defense market in Israel. | |
| On January 9, 2025, Odysight.Ai Eu S.r.l., a wholly owned subsidiary of the Company was incorporated under the laws of Italy. References to the Company include the subsidiaries unless the context indicates otherwise. | |
| The Company, through its subsidiaries, provides vision-based platform solutions for the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. The Company’s video sensor-based solutions and its embedded software, and AI algorithms are deployed in hard-to-reach locations and harsh environments across a variety of PdM and CBM use cases and allow maintenance and operations teams visibility into areas which are inaccessible under normal operation, or where the operating ambience is not suitable for continuous real-time monitoring. Some of the Company’s products utilize micro visualization technology in medical devices for minimally invasive medical procedures. | |
| On February 11, 2025, Company’s completed its uplist and its common stock began trading on the Nasdaq Capital Market under the symbol “ODYS”. Prior to such date, the Company was quoted on the OTCQB under the same symbol. | |
| b. | Since the incorporation of Odysight.ai, and through December 31, 2024, the Company accumulated a deficit of approximately $46 million and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources will allow the Company to fund its operating plan through at least the next 12 months from the filing date of these Consolidated Financial Statements. However, the Company expects to continue to incur significant research and development and other costs related to its ongoing operations, which may require the Company to obtain additional funding in order to continue its future operations until becoming profitable. |
NOTE 2 –SIGNIFICANT ACCOUNTING POLICIES:
a. Basis of preparation:
The consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles in the United States (“U.S. GAAP”) applied on a consistent basis.
b. Use of estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates its assumptions on an ongoing basis, including those related to contingencies and inventory impairment, as well as estimates used in applying its revenue recognition policy. Actual results may differ from these estimates.
c. Functional currency
A majority of Odysight.ai’s revenues are generated in U.S. dollars. The substantial majority of Odysight.ai costs are incurred in U.S. dollars and New Israeli Shekels (“NIS”). Odysight.ai management believes that the U.S. dollar is the currency of the primary economic environment in which Odysight.ai operates. Thus, the functional currency of Odysight.ai is the U.S. dollar.
Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Balances in non-U.S. dollar currencies are translated into U.S. dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-U.S. dollar transactions and other items in the statements of operations (indicated below), the following exchange rates are used: (i) for transactions exchange rates at transaction dates and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization) historical exchange rates. Currency transaction gains and losses are presented in financial income or expenses, as appropriate.
d. Cash and Cash Equivalents
The Company considers as cash equivalents all short-term, highly liquid investments, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.
e. Short-term bank deposits
Bank deposits with maturities of more than three months but less than one year are included in short-term bank deposits. Such short-term bank deposits are stated at cost which approximates fair market value.
f. Restricted deposit
The restricted deposits consist of funds that are contractually restricted as to usage or withdrawal due to guarantees made to the Company’s client.
g. Accounts receivable
Accounts receivable are presented in the Company’s consolidated balance sheets net of allowance for doubtful accounts. The Company estimates the collectability of its accounts receivable balances and adjusts its allowance for doubtful accounts accordingly.
When revenue recognition criteria are not met for a sale transaction that has been billed, the Company does not recognize deferred revenues or the related account receivable.
As of December 31, 2024 and 2023, no allowance for doubtful accounts was recorded.
h. Property and equipment
Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the estimated useful lives.
The annual depreciation rates are as follows:
| % | |
|---|---|
| Machinery and laboratory equipment | 10%-15% |
| Office furniture and equipment | 10% |
| Computers and computer software | 33% |
| Leasehold improvements | Over the shorter of the lease term (including options if any) or useful life |
i. Severance pay
Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (“Section 14”), all of the Odysight.ai’s employees in Israel are entitled to a monthly contribution, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Contributions under Section 14 relieve Odysight.ai from any future severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Company’s balance sheet and there is no liability recorded, as the Company does not have a future obligation to make any additional payments.
The asset and the liability for severance pay presented in the balance sheets reflects employees that began employment prior to automatic application of Section 14.
The severance pay liability of Odysight.ai to its employees that began employment prior to automatic application of Section 14 is based upon the number of years of service and the latest monthly salary of such employees and is partly covered by regular deposits with recognized pension funds and deposits with severance pay funds. Under labor laws, these deposits are in the employees’ names and, subject to certain limitations, are the property of the employees. Odysight.ai records the obligation as if it were payable at each balance sheet date on an undiscounted basis.
j. Stock-Based Compensation
The Company applies the fair value recognition provisions of ASC 718, Compensation—Stock Compensation, or ASC 718, for stock-based awards granted to employees, directors, and other providers for their services.
The Company measures and recognizes compensation expense for its equity classified stock-based awards granted under its plan based on estimated fair values on the grant dates. The Company calculates the estimated fair value of option awards on the grant date using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires a number of assumptions, of which the most significant are the stock price volatility and the expected option term. The Company’s expected dividend rate is zero since the Company does not currently pay cash dividends on its stocks and does not anticipate doing so in the foreseeable future. Volatility is derived from the historical volatility of publicly traded set of peer companies. The risk-free interest rates used in the Black-Scholes calculations are based on the prevailing U.S. Treasury yield as determined by the U.S. Federal Reserve. The weighted average expected life of options was estimated individually in respect of each grant. Each of the above factors requires the Company to use judgment and make estimates in determining the percentages and time periods used for the calculation. If the Company were to use different percentages or time periods, the estimated fair value of option awards could be materially different. The Company recognizes stock-based compensation cost for option awards on an accelerated basis over the employee’s requisite service period, forfeitures are accounted for as they occur.
k. Inventories
Inventories include raw materials, inventory in process and finished products and are valued at the lower of cost or net realizable value.
Inventories are stated at a lower of cost, determined by the first-in, first-out method, or market based on net realizable value. Costs of purchased raw materials and inventory in process include costs of design, raw materials, direct labor, other direct costs and fixed production overheads.
The inventories are adjusted for estimated excess and obsolescence and written down to net realizable value based upon estimates of future demand, technology developments and market conditions.
l. Revenue recognition
| a) | Revenue measurement |
The Company’s revenues are measured according to the ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, revenues are measured according to the amount of consideration that the Company expects to be entitled to receive in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties. Revenues are presented net of VAT.
| b) | Revenue recognition |
The Company recognizes revenue when a customer obtains control over promised goods or services. For each performance obligation, the Company determines at contract inception whether it satisfies the performance obligation over time or satisfies the performance obligation at a point in time.
Performance obligations are satisfied over time if one of the following criteria is met:
(a) the customer simultaneously receives and consumes the benefits provided by the Company’s performance; (b) the Company’s performance creates or enhances an asset that the customer controls as the asset is created or enhanced; or (c) the Company’s performance does not create an asset with an alternative use for the Company and the Company has an enforceable right to payment for performance completed to date.
If a performance obligation is not satisfied over time, the Company satisfies the performance obligation at a point in time.
Revenues from product customization and development contracts in which the performance obligation is satisfied over time are recognized over the duration of the contract and commensurate with the progress of services. The Company measures the progress of services using the input method, based on the effort expended relative to the estimated total effort to satisfy the performance obligation.
Revenues from product sales are recognized at a point in time when the customer obtains control of the Company’s product, typically upon shipment to the customer. Indirect taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.
m. Cost of revenues
Cost of revenue consists of products purchased from sub-contractors, raw materials for in-house assembly line, shipping and handling costs to customers, salary, employee-related expenses, depreciation and overhead expenses.
Cost of revenues are expensed commensurate with the recognition of the respective revenues. Costs deferred in respect of deferral of revenues are recorded as contract fulfilment assets on the Company’s balance sheet and are written down to the extent the contract is expected to incur losses.
**n. Research and development costs **
Research and development costs are expensed as incurred and includes salaries and employee-related expenses, overhead expenses, material, and third-party contractors’ charges.
o. Income taxes
Income taxes are accounted for using the asset and liability approach under ASC-740, “Income Taxes”. The asset and liability approach requires the recognition of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the Company’s financial statements or tax returns.
The measurement of current and deferred tax liabilities and assets is based on provisions of the relevant tax law. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized.
Uncertain tax positions are accounted for in accordance with the provisions of ASC 740-10, under which a company may recognize the tax benefit from an uncertain tax position claimed or expected to be claimed on a tax return only if it is more likely than not that the tax position will be sustained on examination by the taxation authorities, based on the technical merits of the position, at the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Interest and penalties, if any, related to unrecognized tax benefits are recognized in tax expense. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.
p. Legal contingencies
The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. From time to time, the Company may become involved in legal proceedings or subject to claims arising in its ordinary course of business. Such matters are generally subject to many uncertainties and outcomes are not predictable with assurance. The Company accrues for contingencies when the loss is probable and can reasonably estimate the amount of any such loss.
NOTE 2 — SIGNIFICANT ACCOUNTING POLICIES(continued):
q. Basic and diluted net loss per share of common stock:
Basic net loss per share of common stock is computed by dividing net loss, as adjusted, to include the weighted average number of shares of common stock outstanding during the year.
Diluted net loss per share of common stock is computed by dividing net loss, as adjusted, by the weighted average number of shares of common stock outstanding during the year, plus the number of shares of common stock that would have been outstanding if all potentially dilutive shares of common stock had been issued, using the treasury stock method, in accordance with ASC 260-10 “Earnings per Share”.
All outstanding stock options and warrants have been excluded from the calculation of the diluted loss per share for the years ended December 31, 2024 and December 31, 2023, since all such securities have an anti-dilutive effect.
r. Leases
In accordance with ASC 842, the Company determines whether an arrangement is or contains a lease based on the facts and circumstances present at inception of an arrangement. An arrangement is or contains a lease if the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
Arrangements that are determined to be leases at inception are recognized as long-term right-of-use (“ROU”) assets and short and long-term lease liabilities in the consolidated balance sheet at lease commencement. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future fixed lease payments over the lease term at commencement date. As most of the Company’s leases do not provide an implicit rate, the Company applies its incremental borrowing rate based on the economic environment at commencement date in determining the present value of future payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases or payments are recognized on a straight-line basis over the lease term.
The Company has elected not to recognize on the balance sheet leases with terms of 12 months or less.
s. New accounting pronouncements
The Company adopted the following accounting standards during the year:
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures” (“ASU 2023-07”) to improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses on an interim and annual basis. All disclosure requirements of ASU 2023-07 are also required for entities with a single reportable segment. ASU 2023-07 is effective starting January 1, 2024 and should be applied on a retrospective basis to all periods presented. The adoption of this ASU did not have a material impact on the Company’s financial statements (see also Note 16).
Recently issued accounting pronouncements, not yet effective
In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This guidance is intended to enhance the transparency and decision-usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to disclosure regarding rate reconciliation and income taxes paid both in the U.S. and in foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted, with the option to apply the standard retrospectively. The Company is currently evaluating the impact that ASU 2023-09 will have on its related disclosures, and the transition method.
In November 2024, the FASB issued ASU 2024-03, “Income Statement–Reporting Comprehensive Income–Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), which requires the disaggregation of certain expenses in the financial statements notes, to provide enhanced transparency into the expense captions presented on the face of the consolidated statement of operations. ASU 2024-03 is effective for annual reporting periods beginning January 1, 2027 and interim periods beginning January 1, 2028 and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that ASU 2024-03 will have on its related disclosures, and the transition method.
NOTE 3 -INVENTORY:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Raw materials and supplies | 172 | 445 |
| Work in progress | 19 | 34 |
| Finished goods | 12 | 25 |
| Inventory Net | 203 | 504 |
During the years 2024 and 2023, no impairment occurred.
NOTE 4 -PROPERTY AND EQUIPMENT, NET**:**
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Cost: | ||
| Machinery and laboratory equipment | 629 | 626 |
| Leasehold improvements, office furniture and equipment | 177 | 171 |
| Computers and computer software | 281 | 237 |
| Total property and equipment, gross | 1,087 | 1,034 |
| Less: accumulated deprecation | (680) | (557) |
| Total property and equipment, net | 407 | 477 |
Depreciation expenses were $123 thousand and $284 thousand for the years ended December 31, 2024 and 2023, respectively.
NOTE 5 –OTHER CURRENT LIABILITIES:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Government authorities | 79 | 52 |
| Accrued expenses | 261 | 132 |
| Other payables | 28 | 27 |
| Total other current liabilities | 368 | 211 |
NOTE 6 -INCOME TAXES:
| a. | Basis of taxation |
| 1. | Tax rates applicable to the income of the Israeli subsidiaries: |
Odysight.ai is taxed according to Israeli tax laws.
The Israeli corporate tax rate from the year 2018 and onwards is 23%.
| 2. | Tax rates applicable to the income of the U.S. company: |
The Company is taxed according to U.S. tax laws.
The U.S. corporate tax rate from the year 2018 and onwards is 21%.
| b. | Deferred income taxes: |
| Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows: |
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Operating loss carryforward | 34,433 | 25,006 |
| Net deferred tax asset before valuation allowance | 7,991 | 5,786 |
| Valuation allowance | (7,991) | (5,786) |
| Net deferred tax | - | - |
As of December 31, 2024, the Company has provided a full valuation allowance of $7,991 thousand in respect of deferred tax assets resulting from tax loss carryforwards and other temporary differences. Management currently believes that because the Company has a history of losses, it is more likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable future.
NOTE 6 - INCOME TAXES (Continued):
| c. | Available carryforward tax losses: |
| As of December 31, 2024, the Company has an accumulated tax loss carryforward of approximately $34,433 thousand. Carryforward tax losses in Israel are of unlimited duration. Under the Tax Cut and Jobs Act of 2017 (the “Tax Act”) (subject to modifications under the Coronavirus Aid, Relief, and Economic Security Act), federal net operating losses (NOL) incurred in taxable years ending after December 31, 2017 and in future years may be carried forward indefinitely, but the deductibility of such federal net operating losses is limited. It is uncertain if and to what extent various states will conform to the newly enacted federal tax law. | |
| In addition, under Section 382 of the Internal Revenue Code of 1986, as amended, and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50 percentage point change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Such limitations may result in the expiration of net operating losses before utilization. | |
| d. | The main reconciling item between the statutory tax rate of the Company and the effective tax rate is the recognition of valuation allowance in respect of deferred taxes relating to accumulated net operating losses carried forward due to the uncertainty of the realization of such deferred taxes. |
NOTE 7 –RELATED PARTIES:
Related Parties Balances:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Directors (directors’ accrued compensation) | 120 | 31 |
| Smartec R&D Ltd. | - | 10 |
| Related parties | 120 | 41 |
NOTE 8 -EQUITY:
Increase of the authorized share capital
On February 5, 2021, the Company increased its authorized share capital of the Company by an additional 225,000,000 shares of common stock par value $0.001 per share, such that the authorized share capital of the Company following such increase shall be consisting of 300,000,000 shares of common stock.
| a. | Private placement: |
| 1. | On March 29, 2021, the Company issued to certain investors, including Arkin, a major stockholder of the Company, of which Moshe (Mori) Arkin, a director of the company, is the owner, 2,469,156 units in exchange for an aggregate purchase price of $20 million. Each such unit consisted of (i) one share of common stock and (ii) one warrant to purchase one share of common stock with an exercise price of $10.35 per share. Each such warrant is exercisable until the close of business on March 31, 2026. Pursuant to the terms of the foregoing warrants, following April 1, 2024, if the closing price of Company common stock equal or exceeds 135% of the aforementioned exercise price (subject to appropriate adjustments for stock splits, stock dividends, stock combinations and other similar transactions after the issue date of the warrants) for any thirty (30) consecutive trading days, the Company may force the exercise of the warrants, in whole or in part, by delivering to these investors a notice of forced exercise. |
| 2. | On March 16, 2023, the Company consummated a private placement with (i) Moshe Arkin and (ii) The Phoenix Insurance Company Ltd. and Shotfut Menayot Israel – Phoenix Amitim, for the sale of an aggregate amount of 3,294,117 units, at a purchase price of $4.25 per unit resulting in gross proceeds of $14,000,000. Each unit consisted of: (i) one share of common stock and (ii) one warrant to purchase one share of common stock with an exercise price of $5.50 per share. The warrants are immediately exercisable and will expire three years from the date of issuance and will be subject to customary adjustments. |
| 3. | On July 16, 2024, the Company issued 2,144,583 shares of its common stock in consideration for a purchase price of $4.80 per share to new and existing investors, including Mori Arkin and The Phoenix Holdings, through Phoenix Insurance and Phoenix Amitim. The gross proceeds from the issuance of securities offered amounted to approximately $10.3 million. After deducting issuance costs, the Company received proceeds of approximately $9.8 million. |
Warrants:
As of December 31, 2024, the Company had the following outstanding warrants to purchase common stock:
| Number of | ||||
|---|---|---|---|---|
| Shares of | ||||
| Exercise Price · common stock | ||||
| Issuance | Expiration | Per Share | Underlying | |
| Warrant | Date | Date | ($) | Warrants |
| March 2021 Warrant | March 29, 2021 | March 31, 2026 | 10.35 | 2,469,156 |
| March 2023 Warrant | March 27, 2023 | March 26, 2026 | 5.50 | 3,294,117 |
| b. | Stock-based compensation to employees, directors and service providers: |
In February 2020, the Company’s Board of Directors approved the 2020 Share Incentive Plan (the “Plan”).
The Plan initially included a pool of 580,890 shares of common stock for grant to Company employees, consultants, directors and other service providers. On March 15, 2020, the Company’s Board of Directors approved an increase to the Company’s option pool pursuant to the Plan by an additional 64,099 shares of common stock. On June 22, 2020, the Company’s Board of Directors approved an increase to the Company’s option pool pursuant to the Plan by an additional 401,950 shares of common stock. During the second quarter of 2021, the Company’s Board of Directors approved an increase to the Company’s option pool pursuant to the Plan by an additional 777,778 shares of common stock. During the first quarter of 2023, the Company’s Board of Directors approved an increase to the option pool pursuant to the Plan by an additional 1,000,000 shares of common stock.
In June 2024, the Company’s Board of Directors approved the 2024 Share Incentive Plan (the “2024 Plan”).
The 2024 Plan initially included a pool of 234,484 shares of common stock, representing the number of shares remaining available for grant under the 2020 Plan. These shares are available for future grant to Company employees, consultants, directors and other service providers. Shares that were subject to awards granted under either the 2020 Plan or the 2024 Plan that have expired or were cancelled or become un-exercisable for any reason without having been exercised in full shall become available for future grant under the 2024 Plan.
In July, 2024, the Company’s Board of Directors approved an increase to the 2024 Plan’s option pool by an additional 850,000 shares of common stock.
The 2020 Plan and 2024 Plan each provide for the grant of stock options (including incentive stock options and nonqualified stock options), shares of common stock, restricted shares, restricted share units, and other share-based awards.
Stock Option Activity
The following summarizes stock option activity:
| Amount of options | Weighted average exercise price | Weighted Average Remaining Contractual Term (years) | Aggregate Intrinsic Value (in thousands) | |
|---|---|---|---|---|
| $ · $ in thousands | ||||
| Outstanding - January 1, 2023 | 1,560,040 | 3.64 | 5.17 | 2,116 |
| Granted | 986,000 | 3.15 | - | - |
| Forfeited | (90,971) | 3.28 | - | - |
| Outstanding - December 31, 2023 | 2,455,069 | 3.46 | 5.04 | 312 |
| Granted | 795,500 | 4.77 | - | - |
| Forfeited | (23,335) | 3.00 | - | - |
| Outstanding - December 31, 2024 | 3,227,234 | 3.78 | 4.66 | 13,605 |
| Options Exercisable - December 31, 2024 | 1,765,468 | 3.48 | 3.45 | 7,986 |
As of December 31, 2024, the aggregate intrinsic value of options granted is calculated as the difference between the exercise price and the closing price on the same date.
The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model. The weighted-average grant date fair value per option granted during the year ended December 31, 2024 was $4.86. The fair value of each award is estimated using Black-Scholes option-pricing model based on the following assumptions: based on underlying value of shares of $5.55-5.75, exercise price of $4.5-$4.8, expected volatility of 100.61%-101.39%, term of the options –7 years and risk-free interest rate 3.51%-4.23%.
Volatility is derived from the historical volatility of publicly traded set of peer companies. The risk-free interest rates used in the Black-Scholes calculations are based on the prevailing U.S. Treasury yield as determined by the U.S. Federal Reserve. The Company has not paid dividends and does not anticipate paying dividends in the foreseeable future. Accordingly, no dividend yield was assumed for purposes of estimating the fair value of the Company’s stock-based compensation. The weighted average expected life of options was estimated individually in respect of each grant.
The unrecognized compensation expense calculated under the fair-value method for stock options expected to vest as of December 31, 2024 is approximately $3.4 million and is expected to be recognized over a weighted-average period of 1.43 years.
During 2024 and 2023, the Company’s Board of Directors authorized the grant of options to purchase 60,000 shares of common stock of the Company and 150,000 shares of common stock of the Company, respectively, to Prof. Goldwasser, the Chairman of the Board.
During 2024, the Company’s Board of Directors authorized the grant of options to purchase 120,000 shares of common stock of the Company to directors of the Company.
During 2024 and 2023, the Company’s Board of Directors authorized the grant of options to purchase 285,000 shares of common stock of the Company and 225,000 shares of common stock of the Company, respectively, to certain officers of the Company.
Compensation expense recorded by the Company in respect of its stock-based employees, directors and service providers compensation awards in accordance with ASC 718-10 for the year ended December 31, 2024 and 2023 amounted to $2,329 thousand and $1,548 thousand, respectively.
| c. | Restricted stock unit (“RSU”) to employees and service providers: |
Each RSU will vest based on continued service which is generally over three years. The grant date fair value of the award will be recognized as stock-based compensation expense over the requisite service period. The fair value of restricted stock units was estimated on the date of grant based on the fair value of the Company’s common stock.
The following table summarizes RSU activity for December 31, 2024:
| Amount of RSUs | Weighted Average Grant Date Fair Value per Share | Weighted Average Remaining Contractual Term (years) | |
|---|---|---|---|
| $ | |||
| Outstanding - December 31, 2023 | 39,585 | 4.08 | 6.3 |
| Granted | - | - | - |
| Forfeited | - | - | - |
| Vested | (24,166) | 4.42 | - |
| Unvested and Outstanding - December 31, 2024 | 15,419 | 3.56 | 5.5 |
Compensation expense recorded by the Company in respect of its stock-based employees, directors and service providers compensation awards in accordance with ASC 718-10 for the year ended December 31, 2024 and 2023 amounted to $57 thousand and $116 thousand, respectively.
The unrecognized compensation expense calculated under the fair-value method for RSUs expected to vest as of December 31, 2024 is approximately $13 thousand and is expected to be recognized over a weighted-average period of 0.92 years.
The following table sets forth the total stock-based payment expenses resulting from options and RSU granted, included in the statements of operation and comprehensive income:
| Year ended on December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Cost of revenues | 35 | 22 |
| Research and development | 665 | 522 |
| Sales and marketing expenses | 265 | 126 |
| General and administrative | 1,421 | 994 |
| Total expenses | 2,386 | 1,664 |
NOTE 9 –REVENUES AND ENTITY WIDE DISCLOSURES:
| a. | Disaggregation of revenue |
| (1) | During the second quarter of 2022, the Company completed the development of a customer-specific project for a Fortune 500 multinational healthcare corporation (“customer A”) and moved from the development phase of the project to its production phase. As a result, during the year ended December 31, 2024, the Company recognized development services revenues and related development costs that had been previously deferred, in the amounts of $422 thousand and $239 thousand, respectively. The amounts were recognized based on the expected manufacturing term of the product, which the Company estimates at 7 years. |
| In addition, following the commencement of the production phase, the Company recognized product revenues of $2,578 thousand during the year ended December 31, 2024 from the sale of units of the product developed in the context of these development services. | |
|---|---|
| (2) | During the year ended December 31, 2024 the Company recognized revenues from customization and development services in which the performance obligation is satisfied over time in the amount of $863 thousand. |
| b. | Revenues by geographical area (based on the location of customers) |
The following is a summary of revenues within geographic areas:
| Year ended on December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| United States | 3,014 | 2,983 |
| Israel | 911 | 27 |
| Other | 39 | 23 |
| Revenue | 3,964 | 3,033 |
| c. | Major customers |
Set forth below is a breakdown of Company’s revenue by major customers (major customer –revenues from these customers constituted at least 10% of total revenues in a certain year):
| Year ended on | ||
|---|---|---|
| December 31, | ||
| 2024 | 2023 | |
| USD in thousands | ||
| Customer A | 3,000 | 2,977 |
| Customer B | 531 | 27 |
NOTE 9 – REVENUES AND ENTITY WIDE DISCLOSURES(continued):
| d. | Contract fulfillment assets and Contract liabilities: |
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Contract fulfillment assets | 1,017 | 1,256 |
| Contract liabilities | 2,075 | 2,322 |
Contract liabilities include deferred service and advance payments.
The change in contract fulfillment assets:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Balance at beginning of year | 1,256 | 1,495 |
| Contract costs recognized during the period | (239) | (239) |
| Balance at end of year | 1,017 | 1,256 |
The change in contract liabilities:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Balance at beginning of year | 2,322 | 3,644 |
| Deferred revenue relating to new sales | 253 | - |
| Revenue recognized during the year | (500) | (1,322) |
| Balance at end of year | 2,075 | 2,322 |
Remaining Performance Obligations
Remaining Performance Obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that are expected to be invoiced and recognized as revenue in future periods. As of December 31, 2024, the total RPO amounted to approximately $15 million. The total RPO amount includes an amount exceeding $10 million related to a long-term purchase order agreement signed in the third quarter of 2024 with a leading international defense contractor.
NOTE 10 -LEASES
| a. | Omer office space |
In December 2020, Odysight.ai entered into a lease agreement for office space in Omer, Israel (“Original Space”), with the 36-month term for such agreement beginning on January 1, 2021. In March 2021, Odysight.ai entered into a lease agreement for additional office space in Omer, Israel (“Additional Space”), with the term for such agreement ending in December 31, 2023.
On June 25, 2023, Odysight.ai entered into an amendment to these agreements pursuant to which the lease for the Additional Space was shortened and ended on June 30, 2023 and the lease for the Original Space was extended for an additional five years until December 31, 2028. It was also agreed that Odysight.ai has an option to terminate the agreement for the Original Space after three years. Odysight.ai expect that the lease period will be three years.
Monthly lease payments under the agreement for the Original Space are approximately $7 thousand.
| b. | Ramat Gan office space |
In May 2023, Odysight.ai entered into an additional lease agreement for office space in Ramat Gan, Israel. The agreement is for 48 months beginning on July 1, 2023 and the Company has an option to extend the lease period for an additional two years. The Company does not currently expect to extend the lease period. Monthly lease payments under the agreement are in the amount of approximately $25 thousand.
Odysight.ai subleases part of the additional office space in Ramat Gan to an unrelated third party for approximately $7 thousand per month.
In addition, the Company leases vehicles under various operating lease agreements.
On December 31, 2024, the Company’s ROU assets and lease liabilities for operating leases totaled $1,113 thousand and $1,047 thousand, respectively.
On December 31, 2023, the Company’s ROU assets and lease liabilities for operating leases totaled $1,380 thousand and $1,326 thousand, respectively.
Operating lease expenses were $514 thousand and $403 thousand for the years ended December 31, 2024 and 2023, respectively.
Supplemental cash flow information related to operating leases during the period presented was as follows:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Cash paid for amounts included in the measurement of lease liabilities: | ||
| Operating cash flows from operating leases | 514 | 479 |
Lease term and discount rate related to operating leases as of the period presented were as follows:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Weighted-average remaining lease term (in years) | 1.1 | 1.5 |
| Weighted-average discount rate- leases vehicles | 6% | 6% |
| Weighted-average discount rate- leases offices | 12.8% | 12.8% |
NOTE 10 – LEASES(continued):
The maturities of lease liabilities under operating leases as of December 31, 2024 are as follows:
| USD in thousands | |
|---|---|
| Remainder of fiscal year | |
| 2025 | 563 |
| 2026 | 455 |
| 2027 | 160 |
| Total undiscounted lease payments | 1,178 |
| Less: Imputed interest | (131) |
| Total lease liabilities | 1,047 |
NOTE 11 –COST OF REVENUES:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Salaries and related expenses | 1,175 | 836 |
| Stock-based compensation | 35 | 22 |
| Materials and subcontractors | 1,345 | 1,429 |
| Depreciation | 42 | 63 |
| Travel expenses | 27 | - |
| Vehicle expenses | 38 | 49 |
| Rent and maintenance and other expenses | 145 | 125 |
| COST OF REVENUES | 2,807 | 2,524 |
NOTE 12 –RESEARCH AND DEVELOPMENT EXPENSES:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Salaries and related expenses | 3,985 | 3,561 |
| Stock-based compensation | 665 | 521 |
| Materials and subcontractors | 1,535 | 767 |
| Depreciation | 58 | 164 |
| Travel expenses | 65 | 41 |
| Vehicle expenses | 133 | 110 |
| Rent and maintenance and other expenses | 443 | 438 |
| Research and Development expenses | 6,884 | 5,602 |
NOTE 13 –SALES AND MARKETING EXPENSES:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Salaries and related expenses | 251 | 142 |
| Stock-based compensation | 265 | 126 |
| Business development and marketing | 581 | 667 |
| Exhibitions | 84 | 152 |
| Vehicle expenses | 19 | 15 |
| Other expenses | 18 | 7 |
| Sales And Marketing Expenses | 1,218 | 1,109 |
NOTE 14 –GENERAL AND ADMINISTRATIVE EXPENSES:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Salaries and related expenses | 1,503 | 1,132 |
| Stock-based compensation | 1,421 | 994 |
| Professional services | 1,467 | 1,037 |
| Patents | 395 | 486 |
| Depreciation | 23 | 56 |
| Insurance | 211 | 182 |
| Vehicle expenses | 94 | 100 |
| Rent and maintenance and other expenses | 448 | 444 |
| General and Administrative expenses | 5,562 | 4,431 |
NOTE 15 -COMMITMENTS AND CONTINGENCIES
On April 2023, the Company received approval from the Israel Innovation Authority (previously the Office of the Chief Scientist), (the “IIA”) to support and enhance the Company’s production line and capabilities in the next 24 months until April 2025. Pursuant to the agreement with the IIA relating to the program, the Company has to pay royalties of 3% to the IIA up to the amount IIA funding received and the accrued interest repayment of the grant is contingent upon the Company successfully completing its enhancement plans and generating sales from the enhancements preformed. The Company has no obligation to repay these grants if its enhancement plans are not completed or aborted or if it generates no sales.
NOTE 16 —SEGMENT REPORTING
Segment information is prepared on the same basis that the chief executive officer, who is the Company’s chief operating decision maker, manages the business, makes business decisions and assesses performance. The Company has one reportable segment specializing in vision-based platform solutions as described in Note 1.
The Chief Executive Officer assesses performance for this segment and decides how to allocate resource. The measure of segment assets is reported on the balance sheet as total assets. The chief executive officer performs the assessment of segment performance by using the reported measure of segment profit or loss to monitor budget versus actual results.
The table below summarizes the significant expense categories regularly reviewed by the CODM for the years ended December 31, 2024 and 2023:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| USD in thousands | ||
| Revenues | 3,964 | 3,033 |
| Cost of Sales (*) | 2,730 | 2,440 |
| Research and Development expenses (*) | 6,160 | 4,917 |
| Sales and marketing (*) | 951 | 983 |
| General and Administrative expenses (*) | 4,121 | 3,378 |
| Other segment items: | ||
| Share-based payments | 2,386 | 1,664 |
| Depreciation | 123 | 284 |
| Other income | - | 200 |
| Finance income, net | 740 | 988 |
| Net loss | 11,767 | 9,445 |
| (*) | Excluding share-based payments, depreciation expense and finance income, net |
|---|
NOTE 17 -SUBSEQUENT EVENTS:
| a. | On January 9, 2025, the Company formed a wholly-owned subsidiary, Odysight.Ai Eu S.r.l., a private company organized under the laws of Italy. |
|---|---|
| b. | On February 12, 2025, the Company completed a U.S. underwritten public offering issuing 3,307,692 shares of the Company’s common stock at a public offering price of $6.50 per share. The Company also granted the underwriters a 30-day over-allotment option to purchase up to an additional 496,153 shares at a purchase price of $6.50 per share. |
| On February 14, 2025, the Company sold an additional 345,432 shares of common stock as a result of a partial exercise of the over-allotment option at the public offering price of $6.50 per share. | |
| Following the exercise of the over-allotment option, the Company sold a total of 3,653,124 shares of common stock, generating gross proceeds of approximately $23.7 million, prior to the deduction of underwriting discounts, commissions, and estimated offering expenses. | |
| c. | On February 11, 2025, the Company’s common stock began trading on the Nasdaq Capital Market under the symbol “ODYS”. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.